NDC Package Code : 17337-0504
Start Marketing Date : 2020-03-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
66
PharmaCompass offers a list of Bufexamac API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bufexamac manufacturer or Bufexamac supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bufexamac manufacturer or Bufexamac supplier.
PharmaCompass also assists you with knowing the Bufexamac API Price utilized in the formulation of products. Bufexamac API Price is not always fixed or binding as the Bufexamac Price is obtained through a variety of data sources. The Bufexamac Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CP 1044 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CP 1044, including repackagers and relabelers. The FDA regulates CP 1044 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CP 1044 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CP 1044 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CP 1044 supplier is an individual or a company that provides CP 1044 active pharmaceutical ingredient (API) or CP 1044 finished formulations upon request. The CP 1044 suppliers may include CP 1044 API manufacturers, exporters, distributors and traders.
click here to find a list of CP 1044 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CP 1044 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CP 1044 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CP 1044 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CP 1044 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CP 1044 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CP 1044 suppliers with NDC on PharmaCompass.
